-
EP1437143
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1437143
| EP1437143 - INJECTIONS FOR EYE TISSUE CONTAINING DRUG BOUND TO POLYETHYLENE GLYCOL [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 15.08.2014 Database last updated on 02.08.2024 | Most recent event Tooltip | 15.08.2014 | Application deemed to be withdrawn | published on 17.09.2014 [2014/38] | Applicant(s) | For all designated states SANTEN PHARMACEUTICAL CO., LTD. 9-19, Shimoshinjo 3-chome Higashiyodogawa-ku, Osaka-shi Osaka 533-8651 / JP | [N/P] |
| Former [2004/29] | For all designated states SANTEN PHARMACEUTICAL CO., LTD. 9-19, Shimoshinjo 3-chome Higashiyodogawa-ku, Osaka-shi, Osaka 533-8651 / JP | Inventor(s) | 01 /
TASAKA, Humitaka, SANTEN PHARMACEUTICAL CO., LTD. KENKYUSHO, 8916-16, Takayama-cho Ikoma-shi, Nara 630-0101 / JP | 02 /
NAKAGAWA, Masaki, SANTEN PHARMACEUTICAL CO., LTD. KENKYUSHO, 8916-16, Takayama-cho Ikoma-shi, Nara 630-0101 / JP | 03 /
HORIBE, Yoshihide, SANTEN PHARMACEUTICAL CO., LTD. KENKYUSHO, 8916-16, Takayama-cho Ikoma-shi, Nara 630-0101 / JP | 04 /
KUWANO, Mitsuaki, SANTEN PHARMACEUTICAL CO., LTD. KENKYUSHO, 8916-16, Takayama-cho Ikoma-shi, Nara 630-0101 / JP | [2004/29] | Representative(s) | Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Strasse 4 80335 München / DE | [N/P] |
| Former [2013/20] | Ter Meer Steinmeister & Partner Patentanwälte Mauerkircherstrasse 45 81679 München / DE | ||
| Former [2004/29] | TER MEER STEINMEISTER & PARTNER GbR Patentanwälte, Mauerkircherstrasse 45 81679 München / DE | Application number, filing date | 02775260.9 | 27.09.2002 | [2004/29] | WO2002JP10123 | Priority number, date | JP20010299193 | 28.09.2001 Original published format: JP 2001299193 | [2004/29] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO03028765 | Date: | 10.04.2003 | Language: | EN | [2003/15] | Type: | A1 Application with search report | No.: | EP1437143 | Date: | 14.07.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.04.2003 takes the place of the publication of the European patent application. | [2004/29] | Search report(s) | International search report - published on: | JP | 10.04.2003 | (Supplementary) European search report - dispatched on: | EP | 13.04.2007 | Classification | IPC: | A61K47/48, A61K47/34, A61K45/00, A61K9/08, A61P27/02, A61P27/06 | [2004/29] | CPC: |
A61K9/0019 (EP,US);
A61K47/50 (KR);
A61K47/30 (KR);
A61K47/60 (EP,US);
A61K9/0009 (EP,US);
A61K9/0048 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR [2004/29] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | INJEKTIONEN FÜR AUGENGEWEBE MIT AN POLYETHYLENGLYKOL GEBUNDENEM ARZNEIMITTEL | [2004/29] | English: | INJECTIONS FOR EYE TISSUE CONTAINING DRUG BOUND TO POLYETHYLENE GLYCOL | [2004/29] | French: | INJECTIONS POUR TISSU OCULAIRE CONTENANT UN MEDICAMENT LIE A DU POLYETHYLENE GLYCOL | [2004/29] | Entry into regional phase | 31.03.2004 | Translation filed | 31.03.2004 | National basic fee paid | 31.03.2004 | Search fee paid | 31.03.2004 | Designation fee(s) paid | 31.03.2004 | Examination fee paid | Examination procedure | 13.02.2003 | Request for preliminary examination filed International Preliminary Examining Authority: JP | 31.03.2004 | Examination requested [2004/29] | 03.05.2010 | Despatch of a communication from the examining division (Time limit: M06) | 10.11.2010 | Reply to a communication from the examining division | 02.04.2014 | Application deemed to be withdrawn, date of legal effect [2014/38] | 09.05.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2014/38] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 03.05.2010 | Fees paid | Renewal fee | 31.03.2004 | Renewal fee patent year 03 | 26.09.2005 | Renewal fee patent year 04 | 20.09.2006 | Renewal fee patent year 05 | 21.09.2007 | Renewal fee patent year 06 | 26.09.2008 | Renewal fee patent year 07 | 21.09.2009 | Renewal fee patent year 08 | 27.09.2010 | Renewal fee patent year 09 | 20.09.2011 | Renewal fee patent year 10 | 20.09.2012 | Renewal fee patent year 11 | Penalty fee | Additional fee for renewal fee | 30.09.2013 | 12 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9719694 (AMGEN INC [US]) [X] 1-12 * abstract * * page 8, line 20 - line 30 * * page 9, line 10 - line 35 * * page 10, line 17 - line 23 * * page 19, line 3 - page 20, line 33 * * page 25, line 36 - page 26, line 5 *; | [X] - DANIEL W. DROLET; ET AL., "Pharmacokinetics and Safety of an Anti-Vascular Endothelial Growth Factor Aptamer (NX1838) Following Injection into the Vitreous Humor of Rhesus Monkeys", PHARMACEUTICAL RESEARCH, (200012), vol. 17, no. 12, XP002433535 [X] 1-12 * abstract * * page 1503, column L - column R, paragraph 3 * * page 1506; figure 2 * DOI: http://dx.doi.org/10.1023/A:1007657109012 | [XP] - THE EYETECH STUDY GROUP, "Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration", RETINA, philadelphia (US), (200204), vol. 22, no. 2, pages 143 - 151, XP008041866 [XP] 1-12 * page 144, column L, paragraph 4 * * page 145, column R, paragraph 2 * DOI: http://dx.doi.org/10.1097/00006982-200204000-00002 | [XP] - SORBERA, L. A.; ET AL., "Pegaptanib sodium: Treatment of Age-Related Macular Degeneration Treatment of Diabetic Retinopathy anti-VEGF Aptamer", DRUGS OF THE FUTURE, (200209), vol. 27, no. 9, pages 841 - 845, XP002428025 [XP] 1-12 * abstract * * page 842, column L, paragraph 2 * * page 843, column L, paragraph 2 - page 844, column L, paragraph 2; tables 1,2 * DOI: http://dx.doi.org/10.1358/dof.2002.027.09.695013 | International search | [A]WO9300076 (MINNESOTA MINING & MFG [US]); | [X]WO0048535 (GRIMES JAMES B [US]); | [XP]WO0174400 (SANTEN PHARMACEUTICAL CO LTD [JP], et al) |